CIK 0000876343
- Non-accelerated filer
- Smaller reporting company
Lineage Cell Therapeutics, Inc.
Sign in to watch- Ticker
- LCTX
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 943127919
- Phone
- +1 510-521-3390
- Business address
- 2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
- Former names
- BIOTIME INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-30 | Culley Brian M President and CEO | Option exercise | +15,450 | $0.94 | $14K | 180,838 |
| 2020-09-30 | Culley Brian M President and CEO | Shares withheld for taxes | −5,343 | $0.94 | $5K | 175,495 |
| 2020-09-30 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −15,450 | 108,150 | ||
| 2020-07-01 | FARRELL STEPHEN C Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-07-01 | Mulroy Michael H. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-07-01 | BAILEY DON M Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-07-01 | ANDREWS DEBORAH J Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-07-01 | Russell Angus C. Director | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2020-07-01 | KINGSLEY ALFRED D Director | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2020-07-01 | BRADSHER NEAL C Director | Grant or award · OPTION TO PURCHASE COMMON SHARES | +40,000 | 40,000 | ||
| 2020-06-30 | Culley Brian M President and CEO | Option exercise | +15,450 | $0.87 | $13K | 170,731 |
| 2020-06-30 | Culley Brian M President and CEO | Shares withheld for taxes | −5,343 | $0.87 | $5K | 165,388 |
| 2020-06-30 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −15,450 | 123,600 | ||
| 2020-03-31 | Culley Brian M President and CEO | Option exercise | +15,450 | $0.83 | $13K | 160,624 |
| 2020-03-31 | Culley Brian M President and CEO | Shares withheld for taxes | −5,343 | $0.83 | $4K | 155,281 |
| 2020-03-31 | Culley Brian M President and CEO | Option exercise · Restricted Stock Units | −15,450 | 139,050 | ||
| 2020-03-17 | Roberts Brandi CFO & SVP Finance | Grant or award · Employee Stock Option (Right to Buy) | +616,700 | 616,700 | ||
| 2020-03-17 | Leavitt Chase C. General Counsel/Secretary | Grant or award · Employee Stock Option (Right to Buy) | +616,700 | 616,700 | ||
| 2020-03-17 | Hogge Gary S. SVP,Clinical & Medical Affairs | Grant or award · Employee Stock Option (Right to Buy) | +444,000 | 444,000 | ||
| 2020-03-17 | Culley Brian M President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +1,233,300 | 1,233,300 |
Page 10 of 17 · 322 trades